Abstract
It is well established that macrophages play a major role in the resistance to tumors and infections1. In view of this fact, special importance is assumed by the understanding of the mechanism leading macrophages to the aquisition of cytotoxic activity for tumor cells or parasites. Recently, several studies on macrophage activation for tumor cytotoxicity provided evidence that development of macrophages with nonspecific tumoricidal activity is not the result of a single interaction between cell and activation signal, yet it requires the completion of a sequence of reactions2–4 .
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
D.S. Nelson ed.,“Immunobiology of the Macrophage”,Academic Press, New York (1976).
J.B. Hibbs Jr., R.R. Taintor, H.A. Chapman Jr. and J.B. Weinberg, Macrophage tumor killing: Influence of the local environment, Science 197: 279 (1977).
S.W. Russell, W.F. Doe, and A.T. McIntosh, Functional characterization of a stable, noncytolytic stage of macrophage activation in tumors, J. Exp.Med. 146: 1511 (1977).
L.P. Ruco,and M.S. Meltzer, Macrophage activation for tumor cytotoxicity: development of macrophage cytotoxic activity requires completion of a sequence of short-lived intermediacy reactions, J. Immunol. 121: 2035 (1978).
J. Watson and R. Riblet, Genetic control of responses to bacterial lipopolysaccharides in mice. I. Evidence for a single gene that influences mitogenic and immunogenic responses to lipopolysaccharides, J. Exp. Med. 140: 1147 (1974).
L.P. Ruco, and M.S. Meltzer, Defective tumoricidal capacity of macrophages from C3H/HeJ mice, J. Immunol. 120: 329 (1978).
L.P. Ruco, and M.S. Meltzer, Macrophage activation for tumor cytotoxicity: Tumoricidal activity by macrophages from C3H/ HeJ mice requires at least two activation stimuli, Cell. Immunol. 41: 35 (1978).
D. Boraschi,and M.S. Meltzer, Macrophage activation for tumor cytotoxicity: genetic variation in macrophage tumoricidal capacity among mouse strains, Cell. Immunol. 45: 188 (1979).
D. Boraschi, and M.S. Meltzer, Defective tumoricidal capacity of macrophages from A/J mice. I. Characterization of the macrophage cytotoxic defect after in vivo and in vitro activation stimuli, J.Immunol. 122: 1587 (1979).
D. Boraschi,and M.S. Meltzer, Defective tumoricidal capacity of macrophages from P/J mice: Characterization of the macrophage cytotoxic defect after in vivo and in vitro activation stimuli, J. Immunol. 125: 771 (1980).
L.P. Ruco, and M.S. Meltzer, Macrophage activation for tumor cytotoxicity: Increased lymphokine responsiveness of peritoneal macrophages during acute inflammation,J.Immunol. 120: 1054 (1978).
L.S. Kaplow, Simplified myeloperoxidase stain using benzidine dihydrochloride, Blood 26: 215 (1965).
D. Boraschi, and M.S. Meltzer, Defective tumoricidal capacity of macrophages from A/J mice. II. Comparison of the macrophage cytotoxic defect of A/J mice with that of lipid A-unresponsive C3H/HeJ mice, J. Immunol. 122: 1592 (1979).
R. Van Furth, M.M.C. Dusselhoff-Den Dulk, and H. Mattie, Quantitative study on the production and kinetics of mononuclear phagocytes during an acute inflammatory reaction, J. Exp. Med. 138: 6 (1973).
D. Boraschi, and M.S. Meltzer, Defective tumoricidal capacity of macrophages from P/J mice: Tumoricidal defect involves abnormalities in lymphokine-derived activation stimuli and in mononuclear phagocyte responsiveness, J. Immunol. 125: 777 (1980).
R. Evans, and P. Alexander, Rendering macrophages specifically cytotoxic by a factor released from immune lymphoid cells, Transplantation 12: 227 (1971).
D. Boraschi, and A. Tagliabue, Type I interferon-induced enhancement of macrophage-mediated tumor cytolysis and its difference from activation by lymphokines, Eur.J.Immunol. in press.
L. P. Ruco, M.S. Meltzer, and D.L. Rosenstreich, Macrophage activation for tumor cytotoxicity: Control of macrophage tumoricidal capacity by the LPS gene, J. Immunol. 121: 543 (1978).
L.M. Glode, A. Jacques, S.E. Mergenhagen, and D.L. Rosenstreich, Resistance of macrophages from C3H/HeJ mice to the in vitro cytotoxic effects of endotoxin, J. Immunol. 119: 162 (1977).
D. Boraschi, and M.S. Meltzer, Defective tumoricidal capacity of macrophages from A/J mice. III. Genetic analysis of the macrophage defect, J. Immunol. 124: 1050 (1980).
C.C. Little, A possible mendelian explanation for a type of inheritance apparently non-Mendelian in nature, Science 40: 904 (1914).
D. W. Bailey, Recombinant-inbred strains. An aid to finding identity, linkage, and function of histocompatibility and other genes, Transplantation 11: 325 (1971).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1982 Plenum Press, New York
About this chapter
Cite this chapter
Boraschi, D., Mantovani, A. (1982). Genetic Aspects of Macrophage Activation for Tumor Cytotoxicity. In: Rossi, F., Patriarca, P. (eds) Biochemistry and Function of Phagocytes. Advances in Experimental Medicine and Biology, vol 141. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-8088-7_12
Download citation
DOI: https://doi.org/10.1007/978-1-4684-8088-7_12
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-8090-0
Online ISBN: 978-1-4684-8088-7
eBook Packages: Springer Book Archive